Head and Neck Squamous Cell Carcinoma

Quiénes somos

  • 9 de enero de 2024
    NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
  • enero 5, 2024
    Study of TU2218 in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
  • 5 de abril de 2022
    Study of NEO-201 in Solid Tumors Expansion Cohorts
  • 5 de abril de 2022
    A Study of NX-1607 in Adults With Advanced Malignancies
  • 5 de abril de 2022
    Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors